v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues [Abstract]    
Product sales $ 1,327 $ 616
Other revenue 149 95
Total revenues 1,476 711
Cost of revenues 640 359
Gross profit 836 352
Operating expenses:    
Selling, general and administrative 4,220 3,540
Research and development 755 1,072
Total operating expenses 4,975 4,612
Loss from operations (4,139) (4,260)
Other income (expense):    
Interest Income 78 236
Change in fair value of warranty liabilities (4,179) (0)
Other (1) (4)
Total other income (expense), net 4,256 232
Net income (loss) 117 (4,028)
Less: Convertible preferred stock dividends (189) 0
Net loss attributable to common stockholders $ (72) $ (4,028)
Net loss per basic and diluted common share (in dollars per share) $ 0 $ (0.1)
Weighted average common shares used to compute net loss per basic and diluted common share (in shares) 44,155,391 41,415,808
Comprehensive loss:    
Net income (loss) $ (72) $ (4,028)
Comprehensive loss $ (72) $ (4,028)

Source